Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

76
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
76
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fourier spatial attention guided diffusion model for optimizing exposure inconsistencies in endoscopic images.

Scientific reports·2026
Same author

IAPEz retrotransposons regulate the first lineage segregation in mouse pre-implantation development.

Nucleic acids research·2026
Same author

Knowledge, attitude and practice of patients and their family members regarding age-related macular degeneration: a cross-sectional study.

Frontiers in public health·2026
Same author

Field re-entrant superconductivity in Eu-doped infinite-layer nickelates.

Nature·2026
Same author

Structural characterization of recombinant humanized type III collagen cold gel and its effects on the biological functions of HaCaT cells.

Frontiers in medicine·2026
Same author

Enhanced superconductivity and mixed-dimensional behaviour in infinite-layer samarium nickelate thin films.

Nature communications·2026

Related Experiment Video

Updated: Mar 7, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.6K

Association between C1q gene polymorphisms and autoimmune thyroid diseases.

Qiuming Yao1, Jie Li2, Xiaofei An1

  • 1Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai, China.

Archives of Endocrinology and Metabolism
|February 23, 2017
PubMed
Summary

This study investigated C1q gene single nucleotide polymorphisms (SNPs) and their association with autoimmune thyroid diseases (AITD) in the Chinese Han population. Our findings indicate no significant genetic link between common C1q gene SNPs and AITD susceptibility.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.5K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K

Related Experiment Videos

Last Updated: Mar 7, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.6K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.5K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Endocrinology

Background:

  • Autoimmune thyroid diseases (AITD), including Graves' disease and Hashimoto's thyroiditis, are complex conditions with genetic components.
  • The complement system, particularly C1q, plays a role in immune regulation and has been implicated in autoimmune disorders.
  • Understanding the genetic basis of AITD is crucial for developing targeted therapies and preventative strategies.

Purpose of the Study:

  • To investigate the association between common single nucleotide polymorphisms (SNPs) in the C1q gene and the susceptibility to autoimmune thyroid diseases (AITD).
  • To evaluate the potential role of specific C1q gene polymorphisms in the development of Graves' disease and Hashimoto's thyroiditis.
  • To analyze C1q gene polymorphisms in a Chinese Han population to determine their relevance in AITD pathogenesis.

Main Methods:

  • A case-control study was conducted involving 1,003 AITD patients and 880 healthy controls from the Chinese Han population.
  • Five common C1q gene SNPs (rs294185, rs292001, rs682658, rs665691, and rs294179) were genotyped using standard methods.
  • Statistical analyses, including allele and genotype frequency comparisons and haplotype analysis, were performed to assess associations.

Main Results:

  • No statistically significant differences were observed in the frequencies of alleles or genotypes for the five studied C1q gene SNPs between AITD patients and controls.
  • Stratified analyses revealed no association between these C1q gene SNPs and susceptibility to Graves' disease or Hashimoto's thyroiditis.
  • Haplotype analysis did not identify any significant genetic associations between C1q gene polymorphisms and AITD susceptibility.

Conclusions:

  • The study suggests that the five common C1q gene SNPs examined are not associated with AITD susceptibility in the Chinese Han population.
  • These findings contribute to the understanding of the genetic factors influencing AITD, highlighting the lack of a significant role for these specific C1q variants.
  • Further research may be warranted to explore other genetic loci or environmental factors contributing to AITD pathogenesis.